Diacylglycerol Kinases in Signal Transduction.
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Jul 2022
29 Jul 2022
Historique:
received:
29
05
2022
accepted:
27
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
In recent years, the significant research efforts put into the clarification of the PI3K/AKT/mTOR pathway resulted in the approval of the first targeted therapies based on lipid kinase inhibitors [...].
Identifiants
pubmed: 35955558
pii: ijms23158423
doi: 10.3390/ijms23158423
pmc: PMC9369165
pii:
doi:
Substances chimiques
Diglycerides
0
Phosphoinositide-3 Kinase Inhibitors
0
Diacylglycerol Kinase
EC 2.7.1.107
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Int J Mol Sci. 2020 Oct 23;21(21):
pubmed: 33114041
Pharmacol Res. 2021 Nov;173:105900
pubmed: 34547385
Int J Mol Sci. 2021 May 29;22(11):
pubmed: 34072296
Cells. 2021 Dec 18;10(12):
pubmed: 34944087
EMBO Mol Med. 2022 May 9;14(5):e14649
pubmed: 35373916
Int J Mol Sci. 2020 Jul 26;21(15):
pubmed: 32722576
Int J Mol Sci. 2020 Sep 16;21(18):
pubmed: 32947951
Clin Sci (Lond). 2020 Jul 17;134(13):1637-1658
pubmed: 32608491
Front Cell Dev Biol. 2016 Aug 17;4:82
pubmed: 27583247
Int J Mol Sci. 2020 Sep 18;21(18):
pubmed: 32962151